1. Home
  2. GSHD vs NVAX Comparison

GSHD vs NVAX Comparison

Compare GSHD & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goosehead Insurance Inc.

GSHD

Goosehead Insurance Inc.

SELL

Current Price

$44.44

Market Cap

2.4B

Sector

Finance

ML Signal

SELL

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$12.90

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSHD
NVAX
Founded
2003
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
GSHD
NVAX
Price
$44.44
$12.90
Analyst Decision
Buy
Buy
Analyst Count
13
9
Target Price
★ $62.08
$14.11
AVG Volume (30 Days)
496.3K
★ 7.4M
Earning Date
10-26-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 309.76
EPS
★ 1.04
N/A
Revenue
$365,304,000.00
★ $1,123,479,000.00
Revenue This Year
$16.51
N/A
Revenue Next Year
$15.58
N/A
P/E Ratio
$42.31
★ N/A
Revenue Growth
16.15
★ 64.69
52 Week Low
$33.68
$6.20
52 Week High
$79.85
$13.39

Technical Indicators

Market Signals
Indicator
GSHD
NVAX
Relative Strength Index (RSI) 36.90 67.80
Support Level $42.96 $7.93
Resistance Level $46.17 $13.39
Average True Range (ATR) 2.13 0.97
MACD 0.42 0.15
Stochastic Oscillator 35.37 80.96

Price Performance

Historical Comparison
GSHD
NVAX

About GSHD Goosehead Insurance Inc.

Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: